Lexicon s Q2 Revenues Rise 35 Percent on Increased Licensing Fees | GenomeWeb

NEW YORK, Aug. 7 – Lexicon Genetics of The Woodlands, Texas, said Tuesday its second quarter revenues rose to $3.5 million, compared with $2.6 million in the year ago period, as the company posted higher fees from collaborations with pharmaceutical and biotech companies and increased licensing fees for its gene targeting technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.